Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

51.84
-0.5300-1.01%
Post-market: 51.890.0500+0.10%19:45 EDT
Volume:4.64M
Turnover:240.70M
Market Cap:105.34B
PE:13.88
High:52.40
Open:52.17
Low:51.55
Close:52.37
52wk High:61.70
52wk Low:32.38
Shares:2.03B
Float Shares:1.95B
Volume Ratio:1.11
T/O Rate:0.24%
Dividend:1.76
Dividend Rate:3.40%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:43.31%
ROA:9.79%
PB:4.82
PE(LYR):13.88

Loading ...

Earning Preview: GlaxoSmithKline PLC Q4 revenue is expected to increase by 17.57%, and institutional views are bullish

Earnings Agent
·
Jan 28

GSK’s Benlysta Real‑World Study Nears the Finish Line: What Investors Should Watch

TIPRANKS
·
Jan 28

GlaxoSmithKline (GSK) Receives a New Rating from Bank of America Securities

TIPRANKS
·
Jan 27

GSK Rises Monday, Outperforms Market

Dow Jones
·
Jan 27

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Jan 27

GSK Buyout Turns Volatile RAPT Into Food Allergy Cash-Out Story

Simply Wall St.
·
Jan 24

GSK Says China Approves Trelegy Ellipta for Adults With Uncontrolled Asthma

MT Newswires Live
·
Jan 23

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jan 23

GSK Halts Early-Stage Sickle Cell Study, Tweaking the Risk Profile of Its Rare Disease Pipeline

TIPRANKS
·
Jan 23

Another "Miracle Drug" for Growth? Can "Northeast Pharma Darling" Replicate Its "Hormone Legend"?

Deep News
·
Jan 22

GSK and Alector Phase 3 Dementia Trial Ends Early: What Investors Need to Know

TIPRANKS
·
Jan 22

UBS Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jan 21

PRESS DIGEST-British Business - January 21

Reuters
·
Jan 21

Top Midday Gainers

MT Newswires Live
·
Jan 21

Barclays Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jan 21

GSK, Shionogi reach agreement with Pfizer for interest in ViiV Healthcare

TIPRANKS
·
Jan 20

Top Premarket Gainers

MT Newswires Live
·
Jan 20

This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. -- Barrons.com

Dow Jones
·
Jan 20

How Greenland could turn into a Big Tech problem, according to Morgan Stanley's Mike Wilson

Dow Jones
·
Jan 20

GSK's Tesaro Licenses Alteogen Enzyme Technology

MT Newswires Live
·
Jan 20